Alcidion acquires Silverlink Software

Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.

Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. The group integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety and productivity amongst clinical staff through messaging applications, and data capture and interpretation.

Silverlink is one of the largest and last remaining specialist patient administration system (PAS) providers servicing the UK NHS market. It is recognized as being a flexible, cost-effective PAS that can easily integrate with other clinical systems to support a specialist modular system approach, enabling the benefits of a full electronic patient record (EPR/EMR) without single supplier lock-in.

Oaklins’ team in Australia acted as M&A corporate advisor to Alcidion Group Ltd. on the acquisition of Silverlink Software.

Service

M&A buy-side

Parties

“This is the second acquisition Oaklins has advised Alcidion on over the past 18 months. It has played a key role in the successful completion of both transactions. Oaklins consistently provided professional and commercial advice over the course of the transaction, which enabled us to navigate any deal issues that arose. Oaklins and its experienced team continue to show a deep understanding of the industry and remain a key strategic advisor to our company.”

Kate Quirke

Group Managing Director, Alcidion Group Limited

Talk to the deal team

Scott McInnes

Managing Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Sebastian Bell

Director

Sydney, Australia
Oaklins Henslow

View profile Get in touch

Related deals

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Learn more

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

Healthcare

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

Learn more